The medical landscape for diabetes is changing, and these patches represent a promising development. Unlike subcutaneous injections, this approach offers a less invasive way to administer GLP-1 medications. These patches gradually release the medication through the skin offering a consistent dose of the beneficial agent, which can improve glucose l